Pesquisa de referências

Does the legalisation of cannabis for medicinal use impact private health insurer prescription drug expenditures?

Acceso al documento/Access the document
Registro MARC
Tag12Valor
LDR  00000cab a2200000 4500
001  MAP20240000103
003  MAP
005  20240104193916.0
008  240102e20240102esp|||p |0|||b|spa d
040  ‎$a‎MAP‎$b‎spa‎$d‎MAP
084  ‎$a‎344.1
1001 ‎$0‎MAPA20240000110‎$a‎Cook, Amanda C.
24510‎$a‎Does the legalisation of cannabis for medicinal use impact private health insurer prescription drug expenditures?‎$c‎Amanda C. Cook, E. Tice Sirmans and Brenda Wells
520  ‎$a‎We evaluate whether health insurer aggregate prescription drug expenditures change after the legalisation of medicinal cannabis using U.S. health insurer financial filings reported to state insurance regulators and compiled by the National Association of Insurance Commissioners for private health insurers from 2010 to 2018. We analyse this question for health insurers in the individual market, which includes plans sold on the Affordable Care Act exchanges, the small group market, which consists of fully insured plans sold to employers with fewer than 50 employees, and the large group market, which consists of fully insured plans sold to employers with more than 50 employees. For all three markets, the treatment effects are not significant. Thus, we find no impact of medical cannabis legalisation on health insurer prescription drug expenditures, despite the potential disruption to the health insurance market. Had legalisation increased prescription drug expenditures, the increases in cost would have been borne by enrollees, which is troubling since healthcare costs are rising faster than inflation
650 4‎$0‎MAPA20080626310‎$a‎Seguro de asistencia sanitaria
650 4‎$0‎MAPA20080573867‎$a‎Seguro de salud
650 4‎$0‎MAPA20080559236‎$a‎Legislación
650 4‎$0‎MAPA20080563288‎$a‎Medicamentos
650 4‎$0‎MAPA20080540821‎$a‎Drogas
650 4‎$0‎MAPA20210028717‎$a‎Sistema de distribución de medicamentos
650 4‎$0‎MAPA20080579784‎$a‎Costes económicos
651 1‎$0‎MAPA20080638337‎$a‎Estados Unidos
700  ‎$0‎MAPA20200014911‎$a‎Tice Sirmans, E.
7001 ‎$0‎MAPA20240000134‎$a‎Wells, Brenda
7730 ‎$w‎MAP20077100215‎$g‎02/01/2024 Volumen 49 Número 1 - enero 2024 , 15 p.‎$x‎1018-5895‎$t‎Geneva papers on risk and insurance : issues and practice‎$d‎Geneva : The Geneva Association, 1976-
856  ‎$u‎https://link.springer.com/article/10.1057/s41288-022-00284-4#Sec15
85600‎$y‎MÁS INFORMACIÓN‎$u‎mailto:centrodocumentacion@fundacionmapfre.org?subject=Consulta%20de%20una%20publicaci%C3%B3n%20&body=Necesito%20m%C3%A1s%20informaci%C3%B3n%20sobre%20este%20documento%3A%20%0A%0A%5Banote%20aqu%C3%AD%20el%20titulo%20completo%20del%20documento%20del%20que%20desea%20informaci%C3%B3n%20y%20nos%20pondremos%20en%20contacto%20con%20usted%5D%20%0A%0AGracias%20%0A